MAPT and Alzheimer disease: In this study, we aimed to evaluate preoperatively-obtained CSF biomarkers reflecting AD-related Aβ aggregation, tau pathology, neuroinflammation and axonal degeneration and their associations with pre- and postoperative clinical features in Finnish and Swedish iNPH cohorts.